Warning: Undefined variable $count in /home/seniorca/public_html/wp-content/themes/divi-news-child-healthcare/index.php on line 40
Warning: Undefined variable $count in /home/seniorca/public_html/wp-content/themes/divi-news-child-healthcare/index.php on line 121
Health Care M&A Deals, Week Ending August 31, 2018
The Health Care M&A Weekly chart is a selection of transactions announced during the prior week(s). The deals presented here are from our Deal Search Online database, which is updated every business day, in the quarterly report. Visit www.dealsearchonline.com to see how Deal Search Online can help you stay up-to-date on the healthcare market overall, or in a particular sector of interest to your firm. Biotechnology Acquirer Target Price Genentech, Inc. Collaboration on immunotherapeutics $96 million eHealth Acquirer Target Price Alliance MMA, Inc. SCWorx Corp. $50 million True Nature Holding, Inc. ClariCare, Inc. $3 million Harris Healthcare Iatric Systems, Inc. N/A Laboratories, MRI... Read More »
Health Care M&A Deals, Week Ending August 24, 2018
The Health Care M&A Weekly chart is a selection of transactions announced during the prior week(s). The deals presented here are from our Deal Search Online database, which is updated every business day, in the quarterly report. Visit www.dealsearchonline.com to see how Deal Search Online can help you stay up-to-date on the healthcare market overall, or in a particular sector of interest to your firm. Biotechnology Acquirer Target Price bluebird bio, Inc. Collaboration on cancer cell therapy $30 million Sierra Oncology, Inc. Momelotinib $3 million Global Blood Therapeutics, Inc. Worldwide license for inclacumab N/A Harbour BioMed Exclusive license agreement N/A AbbVie Inc. License to... Read More »
Health Care M&A Deals, Week Ending August 17, 2018
The Health Care M&A Weekly chart is a selection of transactions announced during the prior week(s). The deals presented here are from our Deal Search Online database, which is updated every business day. in the quarterly report. Visit www.dealsearchonline.com to see how Deal Search Online can help you stay up-to-date on the healthcare market overall, or in a particular sector of interest to your firm. Biotechnology Acquirer Target Price Pfizer Inc. Collaboration on mRNA-based vaccines $120 million Portage Biotech Inc. SalvaRx Limited $71.7 million Mustang Bio, Inc. License to X-SCID gene therapy N/A Viscogliosi Brothers, LLC OP-1 product line N/A Bayer AG Development collaboration with... Read More »Health Care M&A Deals, Week Ending August 10, 2018
The Health Care M&A Weekly chart is a selection of transactions announced during the prior week(s). The deals presented here are from our Deal Search Online database, which is updated every business day. in the quarterly report. Visit www.dealsearchonline.com to see how Deal Search Online can help you stay up-to-date on the healthcare market overall, or in a particular sector of interest to your firm. Biotechnology Acquirer Target Price Key Biologics Astarte Biologics N/A Astellas Pharma, Inc. Quethera N/A eHealth Acquirer Target Price DHS Group Connect N/A Global Payments Inc. AdvancedMD $700 million Home Health Care & Hospice Acquirer Target Price Simplura Health Group Helping... Read More »
July 2018 Health Care Deals Simmered
July’s deal volume beat the totals posted in July 2017, but didn’t quite match those posted the previous month. The healthcare merger & acquisition market is still going strong, in other words. Not too hot, no sign of getting cold. Preliminary deal volume in July reached 124 transactions, a 10% loss compared with June’s busy 138 transactions but 6% better than the same month in 2017. The services sectors accounted for 58% of the month’s total, but percentage was actually lower than in June, when services made up 62% of the total, and in July 2017, when services made up 67% of the month’s volume. Some sectors that out-performed both the previous month and... Read More »Schedule a demo
Gain access to the best healthcare and long-term care investment intelligence, data, and analysis.
